{"transactions":[{"id":741347,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:23:47.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":2323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2323,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":2323},"source":{"system":"sec-edgar","filing":"0001193125-26-267611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000119312526267611/ownership.xml","form_type":"4"}},{"id":741346,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:23:47.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":70000,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001193125-26-267611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000119312526267611/ownership.xml","form_type":"4"}},{"id":989867,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-24T21:09:24.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."}],"balance_after":13500,"derivative":{"exercise_price":1,"expiration_date":"2035-11-19","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-25-115411","document":"tm2532045-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465925115411/tm2532045-5_4seq1.xml","form_type":"4"}},{"id":1169028,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-18T20:41:01.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":76760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is exercisable in equal annual installments over three years of continuous service to the Issuer after April 17, 2025."}],"balance_after":76760,"derivative":{"exercise_price":2.19,"expiration_date":"2035-04-16","underlying":"Common Stock","underlying_shares":76760},"source":{"system":"sec-edgar","filing":"0000950170-25-055900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341235/000095017025055900/ownership.xml","form_type":"4"}},{"id":1304246,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-13T21:31:25.000Z","date":"2025-01-10","kind":"purchase","planned":false,"acquired":true,"shares":1838,"price":2.72,"value":4999.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025."}],"balance_after":1838,"source":{"system":"sec-edgar","filing":"0001104659-25-003060","document":"tm253156-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465925003060/tm253156-3_4seq1.xml","form_type":"4"}},{"id":1352559,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-25T21:32:16.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."}],"balance_after":18900,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-20","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001104659-24-122590","document":"tm2429436-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465924122590/tm2429436-3_4seq1.xml","form_type":"4"}},{"id":2244487,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-06-03T16:11:27.000Z","date":"2022-06-02","kind":"sale","acquired":false,"shares":4023,"price":0.06,"value":241.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":304377,"source":{"system":"sec-edgar","filing":"0001457612-22-000073","document":"wf-form4_165428706230667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000073/wf-form4_165428706230667.xml","form_type":"4"}},{"id":2247393,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-06-02T16:31:04.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":117244,"price":0.0617,"value":7233.9548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.061 to $0.0628, inclusive."}],"balance_after":308400,"source":{"system":"sec-edgar","filing":"0001457612-22-000069","document":"wf-form4_165420185009155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000069/wf-form4_165420185009155.xml","form_type":"4"}},{"id":2304390,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-05T08:15:25.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":3924,"price":1.25,"value":4905.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":369487,"source":{"system":"sec-edgar","filing":"0001457612-22-000043","document":"wf-form4_164916091313327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000043/wf-form4_164916091313327.xml","form_type":"4"}},{"id":2327185,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-17T16:06:59.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options are scheduled to vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":450000,"derivative":{"exercise_price":1.11,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001457612-22-000026","document":"wf-form4_164754760130122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000026/wf-form4_164754760130122.xml","form_type":"4"}},{"id":2327184,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-17T16:06:59.000Z","date":"2022-03-16","kind":"sale","acquired":false,"shares":11435,"price":1.1,"value":12578.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":373411,"source":{"system":"sec-edgar","filing":"0001457612-22-000026","document":"wf-form4_164754760130122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000026/wf-form4_164754760130122.xml","form_type":"4"}},{"id":2327183,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-17T16:06:59.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date."}],"balance_after":384846,"source":{"system":"sec-edgar","filing":"0001457612-22-000026","document":"wf-form4_164754760130122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000026/wf-form4_164754760130122.xml","form_type":"4"}},{"id":2330681,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-16T17:28:03.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":2080,"price":2.23,"value":4638.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":286003,"source":{"system":"sec-edgar","filing":"0001457612-22-000016","document":"wf-form5_164746606175514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000016/wf-form5_164746606175514.xml","form_type":"5"}},{"id":2330680,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-16T17:28:03.000Z","date":"2021-04-02","kind":"sale","acquired":false,"shares":3794,"price":2.71,"value":10281.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person."}],"balance_after":288083,"source":{"system":"sec-edgar","filing":"0001457612-22-000016","document":"wf-form5_164746606175514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761222000016/wf-form5_164746606175514.xml","form_type":"5"}},{"id":2475334,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-14T00:12:34.000Z","date":"2021-12-09","kind":"grant","acquired":true,"shares":109000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."}],"balance_after":109000,"derivative":{"exercise_price":0.6938,"exercise_date":"2022-01-09","expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":109000},"source":{"system":"sec-edgar","filing":"0001104659-21-149239","document":"tm2135158-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465921149239/tm2135158-8_4seq1.xml","form_type":"4"}},{"id":2590770,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-26T00:31:16.000Z","date":"2021-08-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."}],"balance_after":100000,"derivative":{"exercise_price":1.26,"expiration_date":"2031-08-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-109466","document":"tm2125787d5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465921109466/tm2125787d5_4seq1.xml","form_type":"4"}},{"id":2782052,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2021-03-17T13:56:45.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vesting of these restricted stock units depends on the average closing price of a share of Genocea Biosciences, Inc.'s common stock over the sixty trading days immediately preceding December 31, 2023. The \"target\" number of restricted stock units is reported. Between 75% and 150% of the target number of units may vest on December 31, 2023, with the vesting percentage determined based on actual performance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vesting of these restricted stock units depends on the average closing price of a share of Genocea Biosciences, Inc.'s common stock over the sixty trading days immediately preceding December 31, 2023. The \"target\" number of restricted stock units is reported. Between 75% and 150% of the target number of units may vest on December 31, 2023, with the vesting percentage determined based on actual performance."}],"balance_after":600000,"derivative":{"underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001457612-21-000040","document":"wf-form4_161600378970314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000040/wf-form4_161600378970314.xml","form_type":"4"}},{"id":2782051,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T13:56:45.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":450000,"derivative":{"exercise_price":3.01,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001457612-21-000040","document":"wf-form4_161600378970314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000040/wf-form4_161600378970314.xml","form_type":"4"}},{"id":2782050,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-17T13:56:45.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001457612-21-000040","document":"wf-form4_161600378970314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000040/wf-form4_161600378970314.xml","form_type":"4"}},{"id":2849988,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T11:25:37.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on 4/2/2020 and vests in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":171000,"derivative":{"exercise_price":1.66,"expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001457612-21-000016","document":"wf-form4_161366552090427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000016/wf-form4_161366552090427.xml","form_type":"4"}},{"id":2849987,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T11:25:37.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":19998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on 6/1/2020 and vests in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":86690,"derivative":{"exercise_price":2.72,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":19998},"source":{"system":"sec-edgar","filing":"0001457612-21-000016","document":"wf-form4_161366552090427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000016/wf-form4_161366552090427.xml","form_type":"4"}},{"id":2849986,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-18T11:25:37.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":19998,"price":2.72,"value":54394.56,"ownership":{"direct":true},"balance_after":63750,"source":{"system":"sec-edgar","filing":"0001457612-21-000016","document":"wf-form4_161366552090427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000016/wf-form4_161366552090427.xml","form_type":"4"}},{"id":2849985,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-18T11:25:37.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":16500,"price":1.66,"value":27390.0,"ownership":{"direct":true},"balance_after":43752,"source":{"system":"sec-edgar","filing":"0001457612-21-000016","document":"wf-form4_161366552090427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000016/wf-form4_161366552090427.xml","form_type":"4"}},{"id":2986430,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-11-10T14:45:36.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":4760,"price":2.06,"value":9805.6,"ownership":{"direct":true},"balance_after":4760,"source":{"system":"sec-edgar","filing":"0001457612-20-000176","document":"wf-form4_160503752402158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000176/wf-form4_160503752402158.xml","form_type":"4"}},{"id":3126926,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T16:18:14.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":106688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":106688,"derivative":{"exercise_price":2.72,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":106688},"source":{"system":"sec-edgar","filing":"0001457612-20-000078","document":"wf-form4_159112907688979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000078/wf-form4_159112907688979.xml","form_type":"4"}},{"id":3126925,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T16:18:14.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":27344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Amended and Restated 2014 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest one-fourth (1/4) on each of the first four (4) anniversaries on the date of grant."}],"balance_after":27344,"source":{"system":"sec-edgar","filing":"0001457612-20-000078","document":"wf-form4_159112907688979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000078/wf-form4_159112907688979.xml","form_type":"4"}},{"id":3181773,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-06T16:24:03.000Z","date":"2020-04-02","kind":"grant","acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":187500,"derivative":{"exercise_price":1.66,"expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0001457612-20-000035","document":"wf-form4_158620462528432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000035/wf-form4_158620462528432.xml","form_type":"4"}},{"id":3181772,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-06T16:24:03.000Z","date":"2020-04-02","kind":"grant","acquired":true,"shares":50783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Amended and Restated 2014 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share ofthe Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of March 6, 2020, subject to the Reporting Person's continued service with the Issuer through the vesting date."}],"balance_after":50783,"source":{"system":"sec-edgar","filing":"0001457612-20-000035","document":"wf-form4_158620462528432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000035/wf-form4_158620462528432.xml","form_type":"4"}},{"id":3590478,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-18T13:34:05.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) The option was granted on 02/07/2019 and vests in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":735000,"derivative":{"exercise_price":0.54,"exercise_date":"2019-03-07","expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001457612-19-000038","document":"wf-form4_155293042694222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761219000038/wf-form4_155293042694222.xml","form_type":"4"}},{"id":3590477,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-18T13:34:05.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":15000,"price":0.54,"value":8100.0,"ownership":{"direct":true},"balance_after":119931,"source":{"system":"sec-edgar","filing":"0001457612-19-000038","document":"wf-form4_155293042694222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761219000038/wf-form4_155293042694222.xml","form_type":"4"}},{"id":3665887,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-11T21:00:37.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest as to 1/4th of the shares subject to the option on the first anniversary of the Grant Date and thereafter as to 1/36th of the shares on each subsequent monthly anniversary of February 7, 2020 (rounded down to the nearest whole share, except for the final vesting period, with respect to which all remaining shares will vest)."}],"balance_after":750000,"derivative":{"exercise_price":0.54,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001457612-19-000017","document":"wf-form4_154993682327409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761219000017/wf-form4_154993682327409.xml","form_type":"4"}},{"id":3884045,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-25T20:06:23.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":468000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Company's Board of Directors approved these options on February 8, 2018, subject to stockholder approval of an amendment to the Company's 2014 Equity Incentive Plan (the \"Plan\"); such stockholder approval for the amendment of the Plan was obtained on June 21, 2018. The options commence vesting on February 8, 2018 (the \"Vesting Commencement Date\") and will vest as to 1/4th of the shares subject to the option on the first anniversary of the Vesting Commencement Date and thereafter as to 1/36th of the shares on each subsequent monthly anniversary of the Vesting Commencement Date (rounded down to the nearest whole share, except for the final vesting period, with respect to which all remaining shares will vest), subject to each individual's continued employment with the Company on each such vesting date."}],"balance_after":864000,"derivative":{"exercise_price":0.98,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":468000},"source":{"system":"sec-edgar","filing":"0001457612-18-000066","document":"wf-form4_152997156749848.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761218000066/wf-form4_152997156749848.xml","form_type":"4"}},{"id":3901309,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-07T20:17:58.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 1/12th of the shares underlying the award on the one-month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director through each applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":16.99,"expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-036334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355415/000120919118036334/doc4.xml","form_type":"4"}},{"id":4014143,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-05T21:49:41.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an automatic stock option grant that was made pursuant to the issuer's director compensation policy on November 15, 2017, the date of effectiveness of the registration statement for the issuer's initial public offering. Under the terms of the policy, the Reporting Person received an option to purchase 25,000 shares. Due to a clerical error, the original Form 4 filed on December 1, 2017 erroneously reported an option grant of 7,324 shares. This Amendment to Form 4 is filed solely to correct the share number."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 33.3333% of the shares underlying the award on the first anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the Reporting Person's continued service as a director through each applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":10,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-016529","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355415/000120919118016529/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-01"}},{"id":4066100,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:26:45.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":396000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options granted will vest annually in 48 equal monthly installments beginning on the first monthly anniversary of the grant date. The Company's Board of Directors also approved on February 8, 2018 that, subject to stockholder approval, William D. Clark will receive 468,000 additional options with the same grant date, at the same exercise price and pursuant to the same vesting schedule."}],"balance_after":396000,"derivative":{"exercise_price":0.98,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":396000},"source":{"system":"sec-edgar","filing":"0001457612-18-000015","document":"wf-form4_151848519091641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761218000015/wf-form4_151848519091641.xml","form_type":"4"}},{"id":4094535,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-19T15:21:46.000Z","date":"2018-01-17","kind":"purchase","acquired":true,"shares":25000,"price":0.8,"value":20000.0,"ownership":{"direct":true},"balance_after":82931,"source":{"system":"sec-edgar","filing":"0001457612-18-000001","document":"wf-form4_151639329232626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761218000001/wf-form4_151639329232626.xml","form_type":"4"}},{"id":4145872,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-12-01T22:26:13.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":7324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an automatic stock option grant that was made on November 15, 2017, the date of the effectiveness of the registration statement for the issuer's initial public offering, under the issuer's director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 33.3333% of the shares underlying the award on the first anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the Reporting Person's continued service as a director through each applicable vesting date."}],"balance_after":7324,"derivative":{"exercise_price":10,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":7324},"source":{"system":"sec-edgar","filing":"0000899243-17-027832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355415/000089924317027832/doc4.xml","form_type":"4"}},{"id":4413973,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-01T16:19:52.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":288000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":288000,"derivative":{"exercise_price":4.67,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":288000},"source":{"system":"sec-edgar","filing":"0001355415-17-000002","document":"wf-form4_148840317772190.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000135541517000002/wf-form4_148840317772190.xml","form_type":"4"}},{"id":4562115,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":39189,"kind":"person","name":"Clark William D","position":1,"cik":"0001355415","reported_name":"Clark William D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-11-09T17:29:45.000Z","date":"2016-11-07","kind":"purchase","acquired":true,"shares":2800,"price":3.49,"value":9772.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount adjusted to reflect shares acquired under the registrant's Employee Stock Purchase Plan."}],"balance_after":52205,"source":{"system":"sec-edgar","filing":"0001355415-16-000004","document":"wf-form4_147873057321480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000135541516000004/wf-form4_147873057321480.xml","form_type":"4"}}]}